Skip to main content
logo
Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
73.71
+1.62 (2.25%)
Oct 19, 2026, 10:08 AM EDT - Market open

Dianthus Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1.92.046.242.836.421.48
Revenue Growth
-60.77%-67.35%120.63%-55.96%334.76%-
Gross Profit
1.92.046.242.836.421.48
Operating Income
-217.84-177.93-101.86-48.17-29.71-13.09
Net Income
-192.25-162.34-84.97-43.56-28.48-13.11
Earnings Per Share
-4.11-4.20-2.55-8.45-32.57-3.27
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,190514.43356.97173.7275.497.64
Total Debt
1.291.391.490.590.79-
Net Cash (Debt)
1,189513.04355.48173.1374.77.64
Net Cash Growth
286.39%44.32%105.32%131.76%878.03%-
Net Cash Per Share
25.4413.2910.6733.6085.451.91

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-155.38-129.06-78.18-36.86-29.07-9.9
Capital Expenditures
-0.33-0.21-0.11-0.11-0.14-0.03
Free Cash Flow
-155.71-129.27-78.29-36.97-29.21-9.94
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-11441.39%-8739.34%-1633.75%-1704.67%-462.91%-886.59%
Pretax Margin
-10096.95%-7973.33%-1362.77%-1541.22%-443.76%-888.14%
Profit Margin
-10096.95%-7973.33%-1362.78%-1541.22%-443.76%-888.14%
FCF Margin
-8177.99%-6349.36%-1255.57%-1308.24%-455.18%-673.24%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
2117.81867.84103.4854.53--